• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.A型肉毒杆菌毒素治疗睑痉挛和干眼症患者。
Br J Ophthalmol. 2003 Jan;87(1):54-6. doi: 10.1136/bjo.87.1.54.
2
The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.良性特发性眼睑痉挛对干眼症和眼表炎症的影响。
Am J Ophthalmol. 2014 Mar;157(3):591-7.e1-2. doi: 10.1016/j.ajo.2013.11.014. Epub 2013 Nov 20.
3
Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.肉毒毒素 A 注射治疗原发性眼睑痉挛患者的泪液产生和排出。
Acta Ophthalmol. 2013 Mar;91(2):e108-12. doi: 10.1111/aos.12002.
4
Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment.与良性特发性眼睑痉挛相关的泪液异常特征及肉毒杆菌毒素 A 治疗的改善作用。
Jpn J Ophthalmol. 2020 Jan;64(1):45-53. doi: 10.1007/s10384-019-00705-3. Epub 2019 Dec 10.
5
Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.眼睑痉挛患者肉毒杆菌毒素治疗后眼高阶像差的变化:肉毒杆菌毒素改善了良性特发性眼睑痉挛患者的干眼症状。
Jpn J Ophthalmol. 2016 Nov;60(6):486-491. doi: 10.1007/s10384-016-0469-6. Epub 2016 Aug 8.
6
Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections.肉毒杆菌毒素注射治疗后眼睑痉挛患者的眼表指标
Ophthalmic Plast Reconstr Surg. 2023;39(5):475-478. doi: 10.1097/IOP.0000000000002375. Epub 2023 Mar 16.
7
Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.接受A型肉毒杆菌毒素注射治疗的睑痉挛患者的眼表改变
Eur J Ophthalmol. 2014 Nov-Dec;24(6):830-4. doi: 10.5301/ejo.5000482. Epub 2014 May 1.
8
[Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].[A型肉毒杆菌毒素对面部肌张力障碍患者泪腺功能的影响]
Arq Bras Oftalmol. 2010 Sep-Oct;73(5):405-8. doi: 10.1590/s0004-27492010000500003.
9
Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.肉毒杆菌毒素A治疗眼睑痉挛或半面痉挛后角膜和泪膜的变化
Cornea. 2015 Aug;34(8):906-10. doi: 10.1097/ICO.0000000000000482.
10
[Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].[A型肉毒毒素治疗面部肌张力障碍患者时的泪膜评估]
Arq Bras Oftalmol. 2006 May-Jun;69(3):319-22. doi: 10.1590/s0004-27492006000300007.

引用本文的文献

1
Evaluation of pharmacological activities of medicinal mushrooms in the context of dry eye disease.干眼症背景下药用蘑菇的药理活性评估
Front Pharmacol. 2025 Mar 5;16:1557359. doi: 10.3389/fphar.2025.1557359. eCollection 2025.
2
Tear film lipid layer thickness and blink dynamics in patients with blepharospasm.眼睑痉挛患者的泪膜脂质层厚度与瞬目动力学
BMC Ophthalmol. 2025 Jan 16;25(1):22. doi: 10.1186/s12886-025-03852-z.
3
Effectiveness of 0.3% Hyaluronic Acid Eye Drops for Benign Essential Blepharospasm and Hemifacial Spasm with Botulinum Toxin-induced Dry Eye.0.3%透明质酸钠滴眼液对肉毒杆菌毒素诱发干眼症的良性原发性睑痉挛和半面痉挛的疗效。
Plast Reconstr Surg Glob Open. 2024 Aug 13;12(8):e6050. doi: 10.1097/GOX.0000000000006050. eCollection 2024 Aug.
4
Severe Dry Eye Disease in Charcot-Marie-Tooth Disease: A Comprehensive Case Report.Charcot-Marie-Tooth 病中的严重干燥性眼疾:全面病例报告。
Am J Case Rep. 2023 Nov 15;24:e941094. doi: 10.12659/AJCR.941094.
5
TFOS Lifestyle: Impact of cosmetics on the ocular surface.TFOS 生活方式:化妆品对眼表的影响。
Ocul Surf. 2023 Jul;29:77-130. doi: 10.1016/j.jtos.2023.04.005. Epub 2023 Apr 13.
6
Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.A型肉毒杆菌毒素治疗半面痉挛患者的干眼疾病
Clin Ophthalmol. 2021 Apr 28;15:1775-1782. doi: 10.2147/OPTH.S305817. eCollection 2021.
7
Botulinum Toxin A Injection for the Treatment of Intractable Dry Eye Disease.A型肉毒杆菌毒素注射治疗顽固性干眼病
Medicina (Kaunas). 2021 Mar 8;57(3):247. doi: 10.3390/medicina57030247.
8
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.经结膜与经皮注射肉毒杆菌毒素至泪腺以减少泪液分泌:一项随机对照试验
Toxins (Basel). 2021 Jan 21;13(2):77. doi: 10.3390/toxins13020077.
9
Comments on: Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.关于:长期接受A型肉毒毒素治疗的面肌痉挛患者的眼表状况:一项对照性对侧眼研究的评论
Indian J Ophthalmol. 2020 Jan;68(1):264-265. doi: 10.4103/ijo.IJO_1645_19.
10
Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.肉毒杆菌 A 毒素长期治疗后面神经麻痹患者的眼表面状态:一项对照同眼研究。
Indian J Ophthalmol. 2019 Sep;67(9):1405-1409. doi: 10.4103/ijo.IJO_41_19.

本文引用的文献

1
Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.泪液明胶酶B活性与眼部酒渣鼻患者的IL-1α浓度及荧光素清除率相关。
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2506-12.
2
Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system.肉毒杆菌毒素在自主神经系统神经疾病治疗中的应用。
Arch Neurol. 1999 Aug;56(8):914-6. doi: 10.1001/archneur.56.8.914.
3
Blepharospasm: past, present, and future.眼睑痉挛:过去、现在与未来。
Ophthalmic Plast Reconstr Surg. 1998 Sep;14(5):305-17.
4
Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.对已知会引起眼部刺激的泪膜疾病进行主观评估和客观诊断测试的评估。
Cornea. 1998 Jan;17(1):38-56. doi: 10.1097/00003226-199801000-00007.
5
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia.一项双盲、随机、平行组研究,旨在调查Dysport和保妥适在治疗颈部肌张力障碍方面的剂量等效性。
J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):6-12. doi: 10.1136/jnnp.64.1.6.
6
Botulinum toxin increases tearing in patients with Sjögren's syndrome: a preliminary report.
J Rheumatol. 1997 Sep;24(9):1842-3.
7
Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years.丹麦30至60岁人群中的干燥性角结膜炎和原发性干燥综合征
Acta Ophthalmol Scand. 1997 Jun;75(3):281-6. doi: 10.1111/j.1600-0420.1997.tb00774.x.
8
Evaluation of the lacrimal drainage function by the drop test.通过泪液试验评估泪道引流功能。
Am J Ophthalmol. 1996 Nov;122(5):701-8. doi: 10.1016/s0002-9394(14)70490-8.
9
Quantitative videographic analysis of blinking in normal subjects and patients with dry eye.正常受试者和干眼患者眨眼的定量视频分析
Arch Ophthalmol. 1996 Jun;114(6):715-20. doi: 10.1001/archopht.1996.01100130707012.
10
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.国家眼科研究所/行业干眼症临床试验研讨会报告
CLAO J. 1995 Oct;21(4):221-32.

A型肉毒杆菌毒素治疗睑痉挛和干眼症患者。

Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.

作者信息

Horwath-Winter J, Bergloeff J, Floegel I, Haller-Schober E-M, Schmut O

机构信息

Department of Ophthalmology, Auenbruggerplatz 4, A-8036 Graz, Austria.

出版信息

Br J Ophthalmol. 2003 Jan;87(1):54-6. doi: 10.1136/bjo.87.1.54.

DOI:10.1136/bjo.87.1.54
PMID:12488263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1771456/
Abstract

BACKGROUND

Many patients with essential blepharospasm also show dry eye signs and symptoms. Botulinum toxin A is an effective treatment for reducing spasms in these patients. In this investigation, the effect of botulinum toxin A injections on tear function and on the morphology of the ocular surface in patients suffering from blepharospasm in combination with a dry eye syndrome was investigated.

METHODS

Botulinum toxin A injections were applied to 16 patients with blepharospasm. All patients complained of dry eye symptoms and had reduced tear break up time values. A subjective questionnaire and ocular examinations including tear break up time, Schirmer test without local anaesthesia, and rose bengal staining were evaluated before, 1 week, 1 month, and 3 months after injection. Impression cytology was performed before, 1 month, and 3 months after botulinum toxin A treatment.

RESULTS

Although all patients were relieved of blepharospasm after botulinum toxin injections, only three noticed an improvement in dry eye symptoms. Eight patients noticed no difference and five complained of worsening. Tear break up time was found to be increased 1 week and 1 month after injections. Schirmer test measurements were reduced up to 3 months. Rose bengal staining slightly increased 1 week after injections. Impression cytology showed no definite change in conjunctival cell morphology 1 month and 3 months after botulinum toxin A injections.

CONCLUSION

In the patients presented here suffering from blepharospasm and dry eye, botulinum toxin A injections were effective in relieving blepharospasm but were not successful in treating dry eye syndrome.

摘要

背景

许多原发性睑痉挛患者也表现出干眼的体征和症状。A型肉毒杆菌毒素是减轻这些患者痉挛的有效治疗方法。在本研究中,研究了A型肉毒杆菌毒素注射对合并干眼综合征的睑痉挛患者泪液功能和眼表形态的影响。

方法

对16例睑痉挛患者进行A型肉毒杆菌毒素注射。所有患者均主诉有干眼症状且泪膜破裂时间值降低。在注射前、注射后1周、1个月和3个月对主观问卷和眼部检查进行评估,眼部检查包括泪膜破裂时间、无局部麻醉的泪液分泌试验和孟加拉玫瑰红染色。在A型肉毒杆菌毒素治疗前、治疗后1个月和3个月进行印迹细胞学检查。

结果

尽管所有患者在注射A型肉毒杆菌毒素后睑痉挛均得到缓解,但只有3例患者注意到干眼症状有所改善。8例患者未发现差异,5例患者主诉症状加重。发现注射后1周和1个月泪膜破裂时间增加。泪液分泌试验测量值在3个月内降低。注射后1周孟加拉玫瑰红染色略有增加。印迹细胞学检查显示,A型肉毒杆菌毒素注射后1个月和3个月结膜细胞形态无明显变化。

结论

在此类合并睑痉挛和干眼的患者中,A型肉毒杆菌毒素注射可有效缓解睑痉挛,但对干眼综合征治疗无效。